Translational Chemical Biology: Hunt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena.
|
|
- Asher Neal
- 5 years ago
- Views:
Transcription
1 Translational Chemical Biology: unt for Next Generation Chemical Probes/Drug Candidates in the Cancer Cell Signaling Arena Prabhat Arya 1
2 small molecule binder From enzymes /isolated protein targets Rethinking Drug Discovery Pharma Focus Asia, Nov 2014 Well defined Compact Deep pocket Protein complexes/ signaling pathways 2
3 Map large surface area Shallow surface Combination of several weak interactions Extended hydrophobic interactions Possible hot spots May 14, 2014 Issue Theme: Chemical Biology of Protein-Protein Interactions 3
4 Natural Products as Modulators of PPIs Me Me Me Me N Me FK506 Me Me Me 2 N Eribulin Complex 3D architectures! Dense display of stereo-defined groups 4
5 Growing Faith in the Emerging Chemical Biology Model Modern rganic Synthesis Novel Chemical Toolbox Biologically Relevant Chemical Space Natural Product-like Natural Product-inspired ybrid Natural Products Cell Signaling Biology (Biological Questions/ Novel Assays) Cellular Assays Zebrafish Assays ther rganisms Biophysics and Structural Biology SPR Protein NMR Computational Tools 5
6 Exploring Biologically Relevant Chemical Space Bioactive Natural Products Building Macrocyclic Diversity-based Chemical Toolbox Natural Product- Inspired Substructures Natural product-like 3D architectures Sufficient complexity with a few chiral functional groups Incorporation of stereochemical and skeletal diversity Synthesis in a reasonable time-scale Easy to carry-out follow-up medicinal chemistry studies From Arya Research Team: Chem. & Biol. 145 (2002) and 163 (2005) Curr. pin. Chem. Biol. 247 (2005) Chem. Rev (2009)
7 Large 3D surface area Numerous binding interactions Excellent track record in finding bioactives Functionalized pre-organized dynamic Shapes Rich in chiral display of functional groups Nat. Rev. Drug Disc. 2008, 7,
8 Building A Chemical Toolbox Me Rapamycin N S Latrunculol A N Me Me 2 N Eribulin Epothilone/Ixabepilone 8
9 Latrunculins as Actin Modulators Isolated from Red Sea sponge Negombata magnifica Potent G-actin Inhibitors Latrunculol A is more potent compared to other family members J. Med. Chem. 2008, 51,
10 Latrunculin-derived ybrid Macrocycles Diversity site R 1 N R1 N Me Me PMBN PMBN Madhu Aeluri S S 10
11 Synthesis of ybrid Macrocycles TBDPS Me PMBN S i. Na, allyl bromide DMF,RT,5h ii.tbaf,tf,rt,1h 70%for2steps ~10.0 gms scale Me PMBN S R N EDCI, DMAP, DCM RT,4h,85-90% R N R N Me PMBN S i.g-ii(10mol%) DCM,reflux,3h ii. 2,10%Pd/C Et,RT,12h 60%for2steps Me PMBN S R=i-Pr R=Bn R=i-Bu R=s-Bu R=Me Aeluri, Dasari, Arya, rg. Lett ASAP 11
12 Eribulin as A Tubulin Binder FDA approved anticancer drug (Nov, 2010) marketed by Esai Synthetic analog of a marine sponge natural product, alichondrin B Mechanistically, a unique inhibitor of microtubule dynamics 12
13 ur 1 st Generation ybrid Macrocycles Eribulin Macrocycle N R Jimmidi, Krishna Reddy, Arya rg. Lett ASAP Ravi Kumar Jimmidi 13
14 ybrid Rapamycins Nat Rev Cancer 2006 Me N Me Me Nat Rev Neuroscience
15 ur 1 st Generation Plan Shiva Krishna Reddy Guduru Me N Me 16 Me Practical and scalable synthesis 22-membered macrocyclic ring Imbedded Amino alcohol moiety as the diversity site N 1 R 2 16 N 18 R 1 Krishna Reddy Guduru, Jimmidi, Deora, Arya rg. Lett ASAP 15
16 Collaborative Study: Probing Cancer Stem Cells by Small Molecules Dr. Satish Kitambi Dept of Medical Biochem and Biophysics, Karolinska Institutet Dr. Subhadra Dravida Tran-Scell Biologics yderabad Dr. Kiranam Chatti DRILS yderabad (Zebrafish / Cytoskeleton Signaling) Dr. Prasenjit Mitra DRILS yderabad (Mitochondria Signaling) 16
17 Nat. Rev. Drug Discovery July
18 Nat. Rev. Drug Discovery July
19 ur Collaborative Roadmap Isolation of Cancer Stem Cells (CSCs) from human brain tumor. Validation of Cancer Stem Cells. Identification of small molecules as highly selective killers of CSCs. Understanding of specific pathways affected by small molecule hits! Cell survival assays using CSCs vs cancer cells. Cell survival, proliferation and migration assays with CSCs in zebrafish. 19
20 Cell 2009 Salinomycin C 20
21 Cell 2014 Kitambi Karolinska 21
22 Cell Viability Assay (Cancer Stem Cells Derived from uman Brain Tumor Cells) Inte ensity (a. u) ATP measurement! Me Me N N N NMe from our toolbox Apoptosis inducer (by Caspase 3 activation) Compounds Kitambi Karolinska 22
23 Cancer Stem Cells: Proliferation and Cell Migration in Zebrafish Model! Lateral view of 2 days old zebrafish larvae with DAPI (stains all the nucleus as blue) and the newly transplanted CSC in red Dorsal view of approximately 1 month old zebrafish transplanted with CSCs labelled red brain brain eye Cancer Stem Cells Kitambi Karolinska 23
24 Sincere Thanks to Arya Academic Research Team in Canada (past) and India (2009- present) NRC Canada Genomics and ealth Initiative Science and Technology Park University of Pune Chemical Biology McGill University Chemical Biology Program Broad Institute of arvard and MIT
Recent years have witnessed an expansion in the disciplines encompassing drug
Course overview Recent years have witnessed an expansion in the disciplines encompassing drug discovery outside the pharmaceutical industry. This is most notable with a significant number of Universities
More informationFRAUNHOFER IME SCREENINGPORT
FRAUNHOFER IME SCREENINGPORT Detection technologies used in drug discovery Introduction Detection technologies in drug discovery is unlimited only a biased snapshot can be presented Differences can presented
More informationDruggability & DruGUI. Ahmet Bakan Department of Computational and Systems Biology
Druggability & DruGUI Ahmet Bakan ahb12@pitt.edu Department of Computational and Systems Biology Target Druggability Can a given biological target, such as a protein, bind with high affinity to a drug?
More informationEOS: a Focussed Oncology Company Overview Forum della Ricerca e dell Innovazione Padova, May 16, 2008
Growing and Nurturing Right Ideas EOS: a Focussed Oncology Company Overview Forum della Ricerca e dell Innovazione Padova, May 16, 2008 EOS S.p.A. (Ethical Oncology Science) Via Monte di Pietà 1/A, Milan,
More informationDrug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases
Drug Discovery Targeting the GHKL Superfamily - HSP90, DNA Gyrase, Histidine Kinases (Jason) Xinshan Kang, Boris Klebansky, Richard Fine BioPredict, Inc., 660 KinderKamack Rd., radell, NJ 07649 232 nd
More informationIntroduction to Assay Development
Introduction to Assay Development A poorly designed assay can derail a drug discovery program before it gets off the ground. While traditional bench-top assays are suitable for basic research and target
More informationAdvancing Life Sciences
Advancing Life Sciences Sweden s largest center for life sciences A national resource SciLifeLab, Science for Life Laboratory, is a Swedish national center for molecular biosciences, with the mission to
More informationCall for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas
Call for Pilot Project Applications Chemical Biology for Infectious Diseases NIH Center of Biomedical Research Excellence University of Kansas Applications due: Oct 3 rd, 2016 Anticipated Decision Date:
More informationDesign, docking study and ADME prediction of Chalcone derivatives as potent Tubulin inhibitors
Journal of Computational Methods in Molecular Design, 2014, 4 (1):1-5 Scholars Research Library (http://scholarsresearchlibrary.com/archive.html) ISSN : 2231-3176 CODEN (USA): JCMMDA Design, docking study
More informationInnovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing
Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing Overview Serving biotech and pharma community since 1998 Proven track record of advancing small molecules from
More informationThe Integrated Biomedical Sciences Graduate Program
The Integrated Biomedical Sciences Graduate Program at the university of notre dame Cutting-edge biomedical research and training that transcends traditional departmental and disciplinary boundaries to
More informationTARGET VALIDATION. Maaike Everts, PhD (with slides from Dr. Suto)
TARGET VALIDATION Maaike Everts, PhD (with slides from Dr. Suto) Drug Discovery & Development Source: http://dlab.cl/molecular-design/drug-discovery-phases/ How do you identify a target? Target: the naturally
More informationCase Studies ZoBio
Case Studies 2011 ZoBio ZoBio Corporate Overview Founded as Dutch BV 11/2004 Full access to all lab facilities of UL Self funded (grants and commercial activities) Doubled income 5 consecutive years 9
More informationUniversity of Pennsylvania Perelman School of Medicine High Throughput Screening Core
University of Pennsylvania Perelman School of Medicine High Throughput Screening Core Sara Cherry, Ph. D. David C. Schultz, Ph. D. dschultz@mail.med.upenn.edu (215) 573 9641 67 John Morgan Building Mission
More informationInnovative Medicines Initiative
Innovative Medicines Initiative EMA - EBE Regulatory Conference on ATMPs Salah-Dine Chibout, Novartis Global Head Discovery & Investigative Safety/ Global Head Preclinical Safety Therapeutic Areas IMI
More informationRecent Progress of Interprotein s Research Activities. Interprotein Corporation
Recent Progress of Interprotein s Research Activities - INTENDD and AI-guided INTENDD - Interprotein Corporation 1 Interprotein Corporation Location: Osaka, Japan Year Established: 2001 CEO & President:
More informationBiomolecular Characterization for Rational Drug Design. Maria João Romão
Biomolecular Characterization for Rational Drug Design Maria João Romão UCIBIO@REQUIMTE Applied Molecular Biosciences Unit Chemistry Department - FCT NOVA mjr@fct.unl.pt / http://sites.fct.unl.pt/xtal
More informationAllosteric inhibitors of the NS3 protease from the hepatitis C virus with a new action mechanism
Jornada 2-2012: Zaragoza Allosteric inhibitors of the NS3 protease from the hepatitis C virus with a new action mechanism Zaragoza, 6 de junio de 2012 Content 1. The Research Group 2. The Product a) Target
More informationCentre for Drug Design and Discovery CD3. Centre for Drug Design and Discovery
Centre for Drug Design and Discovery 3 Centre for Drug Design and Discovery The investment fund for innovative small molecule academic drug discovery" 16 June 2010 UCL - Sopartec 3? THE CENTRE FOR DRUG
More informationGenomics Research Center: Current Status & Future Development
Genomics Research Center: Current Status & Future Development Introduction Research in the life sciences has entered a new era after completion of the human genome project and the sequencing of the genomes
More informationCOMPUTER AIDED DRUG DESIGN: AN OVERVIEW
Available online on 19.09.2018 at http://jddtonline.info Journal of Drug Delivery and Therapeutics Open Access to Pharmaceutical and Medical Research 2011-18, publisher and licensee JDDT, This is an Open
More informationProteomics. Manickam Sugumaran. Department of Biology University of Massachusetts Boston, MA 02125
Proteomics Manickam Sugumaran Department of Biology University of Massachusetts Boston, MA 02125 Genomic studies produced more than 75,000 potential gene sequence targets. (The number may be even higher
More informationDocking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin
Docking Studies of the Binding Mode of Dictyostatin and Its Analogues to the Taxoid Binding Site on Tubulin Christopher B. Hackmeyer Spring Hill College Billy W. Day, Ph.D. Department of Pharmaceutical
More informationReal World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research
Real World Drug Discovery A Chemist's Guide to Biotech and Pharmaceutical Research Robert M. Rydzewski ELSEVIER Amsterdam Boston Heidelberg London New York Oxford Paris San Diego San Francisco Singapore
More informationFragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection
Fragment-based screening of enzyme drug targets: Microfluidic mobility shift assay improves confidence in candidate selection Introduction Fragment-based lead discovery is establishing itself as valuable
More informationDHODH: StructureGuided Design of a. New Class of Drugs. Defeating Malaria Together. Meg Phillips, Ph.D. UT Southwestern
DHODH: StructureGuided Design of a New Class of Drugs Defeating Malaria Together Meg Phillips, Ph.D. UT Southwestern 1 Pipeline to development of a DHODH-based anti-malarial 2001 Phillips enzymology/ structure/hts;
More informationKNIME as a Platform for Integrated Hit Finding at Novartis. Patrick S. Lee Ph.D. KNIME Fall Summit 2016 San Francisco 9/16/2016
KIME as a Platform for Integrated Hit Finding at ovartis Patrick S. Lee Ph.D. KIME Fall Summit 2016 San Francisco 9/16/2016 Agenda Overview of ovartis Hit finding in drug discovery KIME integration 2 A
More informationDr Amy Prosser Careers in Research: Industry
www.rsb.org.uk Dr Amy Prosser Careers in Research: Industry @RoyalSocBio #BiologyWeek #RSBcareersDay Careers in Research: Working in the Pharma Industry Dr Amy Prosser My Career History 2011 Completed
More informationMANIFESTO OF STUDIES 2012
MANIFESTO OF STUDIES 2012 1st YEAR Course Teacher Hours Synopsis Evaluation procedure Laboratory Safety Course (Mandatory) Prof. Mancini I. Dr. Provenzani A. 12 General Laboratory Procedures, Equipment
More informationA Review on Microdosing: Reduction in Cost & Time
Human Journals Review Article June 2016 Vol.:6, Issue:3 All rights are reserved by Rupali Yevale et al. A Review on Microdosing: Reduction in Cost & Time Keywords: Microdosing, phase 0, LC-MS and AMS ABSTRACT
More informationProgram overview. SciLifeLab - a short introduction. Advanced Light Microscopy. Affinity Proteomics. Bioinformatics.
Open House Program SciLifeLab Open House in Stockholm November 4, 2015 09:00-16:00 Contact: events@scilifelab.se Program overview 09:00-09:30-10:00-10:30-11:00-11:30-12:00-12:30-13:00-13:30-14:00-14:30-15:00-15:30-09:30
More informationPharmaceutical Informatics and the Pathway to Personalized Medicines
Pharmaceutical Informatics and the Pathway to Personalized Medicines Sangtae Kim and Venkat Venkatasubramanian Purdue University ICCS2007 DDDAS Workshop Beijing May 26-28, 2007 Outline The Grand Challenge
More informationBIOL 461/ 661 Cell Biology 4 Credits Instructor: Dr. Kristin O Brien. T/TH 11:30-1:00, Irving I 208 Office hours: M 9-10, TH 3-4
BIOL 461/ 661 Cell Biology 4 Credits Instructor: Dr. Kristin O Brien Prerequisites: BIOL 362 Principals of Genetics Office: 226 Arctic Health CHEM 321 Organic Chemistry Laboratory: 229 Arctic Health T/TH
More informationThe Major Function Of Rna Is To Carry Out The Genetic Instructions For Protein Synthesis
The Major Function Of Rna Is To Carry Out The Genetic Instructions For Protein Synthesis For example, protein synthesis in human mitochondria relies on a genetic code that Leder and Nirenberg were able
More informationHitting the target in phenotypic drug discovery: Advances in receptor deconvolution
Hitting the target in phenotypic drug discovery: Advances in receptor deconvolution Jim Freeth, Retrogenix, UK Jim.Freeth@retrogenix.com ELRIG Research and Innovation Meeting March 11th 2014 The right
More informationIntroduction to Drug Design and Discovery
Introduction to Drug Design and Discovery Course: Drug Design Course code: 0510412 Dr. Balakumar Chandrasekaran Dr. Bilal Al-Jaidi Assistant Professors, Pharmaceutical Medicinal Chemistry, Faculty of Pharmacy,
More informationPart I. Progress toward the Total Synthesis of Tubulysin Analogs
Part I. Progress toward the Total Synthesis of Tubulysin Analogs Zhiyong Wang Research Topic Presentation September 16, 2006 Ac S Ph C Four Stage of a Cell Cycle G1-S-G2-M A General Look at the Cell Cycle
More informationComputational methods in drug discovery
Computational methods in drug discovery COURSE HIGHLIGHTS v Structure-based drug discovery Ø Binding site identification Ø Molecular docking v Biologics Ø Molecular modelling Ø Protein-Protein docking
More informationCurrent Research. Examples of current research projects:
Current Research Dr Richard Foster Medicinal Chemistry and Chemical Biology Group Leader Medicinal Chemistry Tutor School of Chemistry University of Leeds r.foster@leeds.ac.uk +44 (0)1133435759 Our group
More informationAntibody Discovery at Evotec
Antibody Discovery at Evotec - Overview - Evotec Antibodies Adding value to our partners research Innovative and flexible solutions from target ID to pre-clinical candidate The people A wide therapeutic
More informationSmall-Molecule Drug Target Identification/Deconvolution Technologies
Small-Molecule Drug Target Identification/Deconvolution Technologies Case-Studies Shantani Target ID Technology Tool Box Target Deconvolution is not Trivial = A single Tool / Technology May Not necessarily
More informationDrug Discovery and Development at NIH for Rare and Neglected Diseases September 29, 2009
Drug Discovery and Development at NIH for Rare and Neglected Diseases September 29, 2009 Melissa Ashlock, Christopher P. Austin, Steve Groft Genetic Alliance Posted in the Resource Repository at: http://www.resourcerepository.org/documents/1692/drugdiscoveryanddevelopmentat
More informationHow Targets Are Chosen. Chris Wayman 12 th April 2012
How Targets Are Chosen Chris Wayman 12 th April 2012 A few questions How many ideas does it take to make a medicine? 10 20 20-50 50-100 A few questions How long does it take to bring a product from bench
More informationNANYANG TECHNOLOGICAL UNIVERSITY SEMESTER I EXAMINATION CBC922 Medicinal Chemistry. NOVEMBER TIME ALLOWED: 120 min
AYAG TECLGICAL UIVERSITY SEMESTER I EXAMIATI 2006-2007 CBC922 Medicinal Chemistry VEMBER 2006 - TIME ALLWED 120 min ISTRUCTIS T CADIDATES 1. This examination paper contains TW (2) parts and comprises SIX
More informationMarine Genetic Resources: Experiences in Commercialization. Background
Marine Genetic Resources: Experiences in Commercialization Marc Slattery University of Mississippi, and ational Institute for Undersea Science & Technology cean Biotechnology Center & Repository United
More informationIncludes 'study abroad' Description This lecture module will introduce the following topics: Assessment Assessment Type Exam 1 (100%) Convenor
Biomedical Sciences This edition of the University of Nottingham Catalogue of Modules went to press on 7th September 2011. It was derived from information held on the database. The Catalogue is also published
More informationDiscovery and Development of Highly Selective and Orally Bioavailable Macrocyclic IDO-1 Inhibitors
Discovery and Development of Highly Selective and Orally Bioavailable Macrocyclic IDO-1 Inhibitors 1 Tim Briggs Senior Director, Medicinal Chemistry Ensemble Therapeutics Corp. Ensemble Therapeutics Corp.
More informationGE Healthcare Life Sciences. A year of interaction with Biacore X100
GE Healthcare Life Sciences A year of interaction with Biacore X1 Protein interaction research Real-time monitoring of binding events using surface plasmon resonance (SPR) gives a deep understanding of
More informationPotencial de los productos naturales marinos como agentes anticáncer: La situación de Panamá
RIBECACER Potencial de los productos naturales marinos como agentes anticáncer: La situación de Panamá VIII Simposio Iberoamericano de plantas medicinales y III Simposio Iberoamericano de investigación
More informationChemical Biology In-class discussion: Tethering
In-class discussion: Tethering This discussion will focus on various Tethering Methods described by workers at Sunesis (for a review, see Erlanson et al. Ann. Rev. Biophys. Biomol. Str. 2004). Regarding
More informationPharmacophore modeling, virtual computational screening and biological evaluation studies
Pharmacophore modeling, virtual computational screening and biological evaluation studies Drug discovery process plays an important role in identifying new investigational drug-likes and developing new
More informationCompound Re-Profiling. Dr Robert Scoffin CEO, Cresset
Compound Re-Profiling Dr Robert Scoffin CEO, Cresset What is it? F F F N N H 2 N S O O Br > Compound Re-Profiling or Re-Purposing is the process of finding a new clinical use for an existing treatment
More information6th Form Open Day 15th July 2015
6th Form Open Day 15 th July 2015 DNA is like a computer program but far, far more advanced than any software ever created. Bill Gates Welcome to the Open Day event at the Institute of Genetic Medicine
More informationImpact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation
Impact of Collaborative Robots at The Genomics Institute of the Novartis Research Foundation (GNF) Dan Sipes Novartis Foundation Outline What is GNF? Approach How it works The need for collaborative robots
More informationMadagascar periwinkle (Catharanthus roseus) Salix - willow. Biodiversity: Use it or lose it. Biodiversity: Use it or lose it
Applying basic ecological science to make a difference Human Impact on Earth s Ecosystems ~50% of land surface and accessible fresh water used by humans C increase is leading to climate change H H H H
More informationSection 10. Junaid Malek, M.D.
Section 10 Junaid Malek, M.D. Cell Division Make sure you understand: How do cells know when to divide? (What drives the cell cycle? Why is it important to regulate this?) How is DNA replication regulated?
More informationInnovative Strategies to Accelerate Academic Drug Discovery. Vincent Groppi, Ph.D Director Center for the Discovery of New Medicines
Innovative Strategies to Accelerate Academic Drug Discovery Vincent Groppi, Ph.D Director Center for the Discovery of New Medicines 9 out of 10 Drugs Fail Hay, Thomas, Craighead, Economides & Rosenthal.
More informationCompeting & Collaborating to Achieve Successful Drug Repositioning
Competing & Collaborating to Achieve Successful Drug Repositioning Noel Southall, Ph.D. National Human Genome Research Institute National Institutes of Health July 14, 2011 NIH Chemical Genomics Center
More informationCONTRACTING ORGANIZATION: Dana Farber Cancer Institute Boston, MA 02115
AWARD NUMBER: W81XWH-13-1-0212 TITLE: Targeting TMPRSS2-ERG in Prostate Cancer PRINCIPAL INVESTIGATOR: David Takeda CONTRACTING ORGANIZATION: Dana Farber Cancer Institute Boston, MA 02115 REPORT DATE:
More informationTanja Krainz Current Literature July 9 th, 2016
Discovery and Characterization of BMN673 (Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1,2 Inhibitor, as an Anticancer Agent Wang, B.; Chu, D.; Feng, Y.; Shen,
More informationUsing Computational Chemistry to Identify New Uses for Old Medicines
Using Computational Chemistry to Identify New Uses for Old Medicines http://www.re-pharm.com alan@re-pharm.com Re-Pharm summary > Clinical-stage company actively building a drug development pipeline >
More informationOverview and Status Update
T H E S C R I P P S R E S E A R C H I N S T I T U T E S C R I P P S F L O R I D A T H E S C R I P P S R E S E A R C H I N S T I T U T E Scripps Florida Overview and Status Update 7 November 2011 Harry
More informationGeneration of research tools to translate genomic discoveries into drug discovery projects. Nils Ostermann, Novartis
Generation of research tools to translate genomic discoveries into drug discovery projects Nils Ostermann, Novartis Need for public-private collaboration Common interest Genomic information is growing
More informationBIO8041 BIO3030. Antimicrobial Drug Discovery
BIO8041 BIO3030 Antimicrobial Drug Discovery Module overview Intended Knowledge Outcomes The aim of this module is to demonstrate various routes to the discovery of microbial products with commercial value.
More informationOTC-BB STOCK SYMBOL: ENZB EXECUTIVE SUMMARY
OTC-BB STOCK SYMBOL: ENZB EXECUTIVE SUMMARY EnzymeBioSystems ( ENZB ), a Nevada corporation, was founded on June 26, 2009, for the purpose of utilizing enzyme technologies to develop commercial solutions
More informationNorth Carolina Research Campus Kannapolis, NC
North Carolina Research Campus Kannapolis, NC Why me? Came from Kannapolis area to UNC in 1966 Began working in RTP in 1971 (RTP had begun in the late 50s) Part of the reason for RTP was to keep people
More information20S Proteasome Assay Kit
20S Proteasome Assay Kit Item No. 10008041 www.caymanchem.com Customer Service 800.364.9897 Technical Support 888.526.5351 1180 E. Ellsworth Rd Ann Arbor, MI USA TABLE OF CONTENTS GENERAL INFORMATION 3
More informationApplication of Deep Learning to Drug Discovery
Application of Deep Learning to Drug Discovery Hase T, Tsuji S, Shimokawa K, Tanaka H Tohoku Medical Megabank Organization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure
More informationCOURSES IN BIOLOGICAL SCIENCE. Undergraduate Courses Postgraduate Courses
COURSES IN BIOLOGICAL SCIENCE Undergraduate Courses Postgraduate Courses Undergraduate Courses: BISC 001 Appreciation of Biological Sciences [3-0-0:3] Diversity of life forms; origin of life; chemical
More informationMarineinspired Oncology
Marineinspired Oncology Nature distributed medicine everywhere. Pliny the Elder. 74 AD 2 3 Leaders in marine biotecnology Group structure Oncology Company Other business PharmaMar is a global biopharmaceutical
More informationMANIFESTO OF STUDIES 2013
MANIFESTO OF STUDIES 2013 1st YEAR - MANDATORY COURSES - Course Teacher Hours Synopsis Evaluation procedure Laboratory Safety Course (Mandatory) Prof. Mancini I. Dr. Provenzani A. 12 General Laboratory
More information= -1-EUROPEAN CD3. "Stimulating innovation in drug discovery" 21 May 2010 Innovation in Healthcare. Centre for Drug Design and Discovery
Centre for Drug Design and Discovery CD3 Centre for Drug Design and Discovery "Stimulating innovation in drug discovery" 21 May 2010 Innovation in Healthcare = -1-EUROPEAN FUND PROVINOE \/laams 8RABANT
More informationPolypharmacology. Giulio Rastelli Molecular Modelling and Drug Design Lab
Polypharmacology Giulio Rastelli Molecular Modelling and Drug Design Lab www.mmddlab.unimore.it Dipartimento di Scienze della Vita Università di Modena e Reggio Emilia giulio.rastelli@unimore.it Magic
More informationConcept of Integrated Research Platforms
Concept of Integrated Research Platforms Michal Vlasin UVPS Brno, Czech Republic Lumir Krejci October 21, 2010 INTEGRATED RESEARCH PLATFORMS AC: Animal Center CBCE: Center of Biomolecular and Cellular
More informationMedicinal Chemistry of Modern Antibiotics
Chemistry 259 Medicinal Chemistry of Modern Antibiotics Spring 2012 Lecture 5: Modern Target Discovery & MOA Thomas Hermann Department of Chemistry & Biochemistry University of California, San Diego Drug
More informationMedicinal Chemistry of Modern Antibiotics
Chemistry 259 Medicinal Chemistry of Modern Antibiotics Spring 2008 Lecture 5: Modern Target Discovery & MOA Thomas Hermann Department of Chemistry & Biochemistry University of California, San Diego Drug
More informationDNA REPLICATION & BIOTECHNOLOGY Biology Study Review
DNA REPLICATION & BIOTECHNOLOGY Biology Study Review DNA DNA is found in, in the nucleus. It controls cellular activity by regulating the production of, which includes It is a very long molecule made up
More informationAdvanced Therapeutic Antibody Discovery with Multiplexed Screening
Advanced Therapeutic Antibody Discovery with Multiplexed Screening White Paper Scientists need powerful tools that can deliver results to fully understand the ability of candidate antibodies to interrupt
More informationChemical Peptide Synthesis in the Development of Protein Therapeutics
Chemical Peptide Synthesis in the Development of Protein Therapeutics Stephen Kent Abstract Effective automated SPPS is key to the synthesis of peptide building blocks for chemical protein synthesis, and
More informationApplication of Deep Learning to Drug Discovery
Application of Deep Learning to Drug Discovery Hiroshi Tanaka Tohoku Medical Megabank Orga nization, Tohoku University Current Situation of Drug Discovery Rapid increase of R&D expenditure More than 1B
More informationTargeting the Functional Activity of PrP C as a Novel Strategy for Drug Discovery in Prion Diseases
Targeting the Functional Activity of PrP C as a Novel Strategy for Drug Discovery in Prion Diseases Emiliano Biasini Department of Biochemistry Boston University School of Medicine One protein, two forms:
More informationMarch 8 [FRI], :00-17:00. - Program -
International Joint Seminar between School of Pharmaceutical Sciences, Peking University, & School of Pharmacy/Pharmaceutical Sciences, Kanazawa University in Kanazawa March 8 [FRI], 2013. 14:00-17:00
More informationTargeted Protein Degradation Therapeutics
Targeted Protein Degradation Therapeutics Hijacking Ubiquitin E3 Ligases Using PROTAC Technology to Effectively Degrade BRD4 and Achieve Anti- tumor Efficacy Yimin Qian; Kanak Raina; Jing Lu; Martha Altieri;
More informationThe main goal of the strategic partnership is the development of innovative, all-natural cosmetic active ingredients and aroma molecules.
PRESS RELEASE Symrise: Strategic partnership with BRAIN and AnalytiCon Discovery (Holzminden/Potsdam/Zwingenberg, April 2, 2007) Symrise GmbH & Co. KG, the world s fourth-largest supplier of fragrance
More informationTime allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section B and ONE question from Section C.
UNIVERSITY OF EAST ANGLIA School of Biological Sciences Main Series UG Examination 2017-18 CELL BIOLOGY BIO-5005B Time allowed: 2 hours Answer ALL questions in Section A, ALL PARTS of the question in Section
More informationSUPPLEMENTARY INFORMATION Figures. Supplementary Figure 1 a. Page 1 of 30. Nature Chemical Biology: doi: /nchembio.2528
SUPPLEMENTARY INFORMATION Figures Supplementary Figure 1 a b c Page 1 of 0 11 Supplementary Figure 1: Biochemical characterisation and binding validation of the reversible USP inhibitor 1. a, Biochemical
More informationleading the way in research & development
leading the way in research & development people. passion. possibilities. ABBVIE 2 immunology AbbVie Immunology has a demonstrated record of success in identifying and developing both small molecule and
More informationTime-resolved interaction analysis on living cells: Comprehensive data generates new knowledge and better decisions
Time-resolved interaction analysis on living cells: Comprehensive data generates new knowledge and better decisions Karl Andersson CEO karl@ridgeview.eu Karl Andersson, PhD Ridgeview Instruments AB Molecular
More informationThe ChEMBL Database. ICIC 2012 Berlin, Germany October John P. Overington EMBL- EBI.
The ChEMBL Database ICIC 2012 Berlin, Germany October 2012 John P. Overington EMBL- EBI jpo@ebi.ac.uk Chemical Space All compounds Drug-like compounds Available compounds Only certain molecules have features
More informationDennis Wright, Ph.D. Professor of Medicinal Chemistry NPDD Initiative UCONN School of Pharmacy University of Connecticut
Craig M. Crews, Ph.D. Lewis B. Cullman Professor of Molecular, Cellular, and Developmental Biology Chemistry, Pharmacology Center for Molecular Discovery Yale University Dennis Wright, Ph.D. Professor
More informationDevelopment and Utilization of Bromodomain and Extra Terminal Domain (BET) Assays Using AlphaLISA Technology
APPLICATION NOTE AlphaLISA Technology Authors: Hong Cao Daniel Cardillo Jen Carlstrom Dawn Nida PerkinElmer, Inc. Hopkinton, MA Development and Utilization of Bromodomain and Extra Terminal Domain (BET)
More informationIntroducing the Department of Life Sciences
Introducing the Department of Life Sciences Life Sciences is a discipline that aims at a fundamental understanding of life phenomena by exploring complex and mysterious structures and funct ions of living
More informationThe Kinase Knowledgebase
The Kinase Knowledgebase Kevin P. Hambly Product Manager Derek A. Debe, Ph.D. Chief Scientific Officer Outline About Eidogen-Sertanty Kinase Knowledgebase Overview Content Curation Process Data Structure
More informationFig. 1. A schematic illustration of pipeline from gene to drug : integration of virtual and real experiments.
1 Integration of Structure-Based Drug Design and SPR Biosensor Technology in Discovery of New Lead Compounds Alexis S. Ivanov Institute of Biomedical Chemistry RAMS, 10, Pogodinskaya str., Moscow, 119121,
More informationCentre for Synthetic Biology
Centre for Synthetic Biology Preface Introduction The Groningen Centre for Synthetic Biology (CSB) was established to foster research expertise in the emerging field of synthetic biology. It incorporates
More informationProducts & Services. Customers. Example Customers & Collaborators
Products & Services Eidogen-Sertanty is dedicated to delivering discovery informatics technologies that bridge the target-tolead knowledge gap. With a unique set of ligand- and structure-based drug discovery
More informationTITLE: Prostate Specific Antigen-Triggered Prodrug of S-Trityl-L-Cysteine, an Eg5 Kinesin Inhibitor and Antimitosis Agent with Low Neurotoxicity
AD Award Number: W81XWH-07-1-0118 TITLE: Prostate Specific Antigen-Triggered Prodrug of S-Trityl-L-Cysteine, an Eg5 Kinesin Inhibitor and Antimitosis Agent with Low Neurotoxicity PRINCIPAL INVESTIGATOR:
More informationCourse Handbook MSc in Bioengineering Tissue Engineering Specialisation
Course Handbook 2013-2014 MSc in Bioengineering Tissue Engineering Specialisation 1 Course Objectives & Learning Outcomes This programme aims to give a sound and broad basis in tissue engineering. In particular,
More informationPractical Workshop: Chemical Biology, Drug Discovery and Screening
Practical Workshop: Chemical Biology, Drug Discovery and Screening Date: 23-25 October 2013 Location: European ScreeningPort GmbH, Schnackenburgallee 114, 22525 Hamburg, Germany Course overview The emergence
More informationSabrina Jedlicka 9/24/2012. NEUROENGINEERING: Interactions of Neurons and Materials
Sabrina Jedlicka 9/24/2012 NEUROENGINEERING: Interactions of Neurons and Materials What is neuroengineering? Neuroengineering combines engineering and computational approaches to problems in basic and
More information